Addressing Inequities in Cancer Clinical Trial Design: Dr. Marya L. Shegog’s Insight [Video]

In this eye-opening video, Dr. Marya L. Shegog, PhD, MPH, CHES, from the Lazarex Cancer Foundation in the San Francisco Bay Area, discusses the current state of cancer clinical trial design and the inequities that exist for participants. Dr. Shegog points out that, unfortunately, clinical trials are not always designed and conducted in a way that is equitable for all.

One major barrier she highlights is the issue of travel, particularly when participants are required to be at the trial site for an extended period. This can be especially challenging for those who are not financially stable or retired, as they may not have the means to afford accommodations near the trial site. Dr. Shegog also notes that clinical trials are often not designed with working individuals in mind, creating additional obstacles to participation.

Furthermore, Dr. Shegog addresses the complex relationship between health insurance and clinical trials, which don’t always work seamlessly together. She emphasizes the need for changes in clinical trial design to improve accessibility and equity for all potential participants.

The Lazarex Cancer Foundation is committed to identifying and addressing these inequities, working tirelessly to ensure that everyone has an equal opportunity to participate in and benefit from cancer clinical trials. To learn more about their mission and how you can support their efforts, please visit their website at https://lazarex.org/diversity-in-cancer-clinical-trials/

Share this video to raise awareness about the current challenges in cancer clinical trial design and the importance of creating a more equitable and inclusive system for all.

#CancerClinicalTrials #HealthEquity #LazarexCancerFoundation #ClinicalTrialDesign #PatientAdvocacy